Dr. Robert A. Nagourney, MD
Hitting Cancer True and Straight: the Role of Tissue Analysis
Although she showed some response, her disease persisted and she was being considered for surgery to remove the residual tumor...
top of page
Nagourney Cancer Blog
Dr. Robert A. Nagourney, MD
- Oct 25
- 3 min
Recurrent Lung Cancer Patients Need To “Get Down On It”
George Brown is alive today because our laboratory analysis identified a simple 2 drug combination that now one else thought to give him.
Dr. Robert A. Nagourney, MD
- Oct 10
- 3 min
A Triple Negative Breast Cancer Patient's Journey: Going the Extra Mile
This patient had recurrent breast cancer that upon biopsy proved to be triple negative.
Dr. Robert A. Nagourney, MD
- Sep 26
- 2 min
Your Cancer Cure May Already Exist
Personalized treatment means more cured patients. More people survive cancer when our Functional Profiling system is used before treatment.
Dr. Robert A. Nagourney, MD
- Aug 30
- 2 min
Pancreatic Cancer Surgery: Know What You Have Consented To!
However, a new dilemma has arisen; the failure of surgeons to comply with Pancreatic Cancer patient’s wishes to have tissue submitted.
Dr. Robert A. Nagourney, MD
- Aug 14
- 3 min
“New” Immune Therapy Active in Late-Stage Cancer Patients
Here in 2023, we
suddenly discover that TIL cells are highly active against cancer, but it was Steven Rosenberg who first described it.
Dr. Robert A. Nagourney, MD
- Jul 24
- 2 min
Stage 4 Cancer Patient Survivals: The Data Is In and It’s Not Good
There has been talk of improved survival in cancer, most progress has reflected screening, early diagnosis, improved staging, and support.
Dr. Robert A. Nagourney, MD
- Jun 26
- 3 min
Challenging Paradigms: The Management of Rectal Cancer
One noteworthy case was a 78-year-old patient successfully treated without surgery.
Dr. Robert A. Nagourney, MD
- Jun 2
- 2 min
Breakthrough for Young Patients with a Rare Form of Liver Cancer
Extremely rare liver cancer that mostly affects people in their twenties associated with a gene rearrangement, mostly lethal, until now.
Dr. Robert A. Nagourney, MD
- May 19
- 3 min
For Medical Oncology, Déjà Vu All Over Again
Patients are being encouraged to contact the researchers to get biopsies and help take charge of their disease.
Dr. Robert A. Nagourney, MD
- May 15
- 4 min
Nagourney Cancer Institute: 20-year Experience in 10,000 Patients
At the 2023 American Association for Cancer Research meeting in Orlando, we reported results of ex vivo analysis of programmed cell death.
Dr. Robert A. Nagourney, MD
- Mar 27
- 2 min
Benefits of Combining Functional Profiling with Nagourney Cancer Institute's 11,000 Patient Studies
Combining Functional Profiling with Nagourney Cancer Institute's 11,000 patient studies provides personalized cancer treatment plans.
bottom of page